Klaire Labs (SFI USA) Announces Availability of probiotic Target gb-X™ (April 2018) Townsend Letter, Alternative Medicine Magazine

From the Townsend Letter
April 2018

Order this issue!

Klaire Labs (SFI USA) Announces Availability of Target gb-X™
The first commercially available gut-brain focused probiotic blend for clinically-demonstrated mood support

Share this article...

Klaire Labs (SFI USA) today announced availability of Target gb-X™ with Ecologic BARRIER, a unique nine-strain blend to support positive mood. This shelf stable, 5B CFU probiotic was specifically designed to influence the gut-brain axis through defined mechanisms including strengthening of the gut barrier function, modulation of cytokines and inflammatory response, neuroprotective metabolite production, and HPA axis.

Target gb-X™ was formulated and developed in partnership with Winclove Probiotics (Amsterdam, NL), a company that researches, develops and manufactures evidence-based probiotics.

"Target gb-X™ is a clinically-researched, safe, and effective way to support patients with mood-related concerns," said Jeremy Appleton, ND, Vice President of Regulatory Affairs at Klaire Labs. "This product is the first in a line of Klaire Labs' targeted, indication-specific probiotics. We are very excited to continually support our practitioner partners with innovative, evidence-based products."

The product will be launched officially at the Integrative Healthcare Symposium (IHS) in New York, 22-24 Feb. Klaire Labs will be sponsoring an evening symposium discussing the mechanisms, the clinical evidence, and one psychiatrist's experience with the formulation.

Target gb-X™ is currently available for pre-order. This formulation is available as shelf-stable, hypoallergenic*, non-GMO, single serving sachets. For more information and product updates, visit meetklaire.com or stop by the Klaire Labs booth (100) at IHS.

*Free of the following common allergens: milk/casein, fish, shellfish, tree nuts, peanuts, wheat, gluten, and soybeans. No artificial additives, colors, flavorings, preservatives, sugar, or salicylates are used. Contains corn.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease

The Townsend Letter is dedicated to examining and reporting on functional and integrative medicine. Our editorial content depends on support from readers like you, and we would appreciate your help to keep this content forthcoming. Please take this opportunity to contribute $50, or choose one of the other amounts listed on the next page, and ensure that our independent voices keep up the good fight against the skeptics, who would like to silence us and eliminate your medical freedoms.

About Klaire Labs
Klaire Labs has been formulating and manufacturing premium, hypoallergenic supplements sold through healthcare practitioners for nearly half a century. Our mission is to develop and manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians with consistently reliable performance.

Klaire Labs is located in Reno, Nevada. It is owned by Soho Flordis International, a privately held nutraceutical company based in Sydney, Australia.

Media Contact
Caitlin Hadley
BrandHive for Klaire Labs
caitlin@brandhive.com

Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine
magazine, which is published 10 times each year. Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices. Once you find the magazines you'd like to order, please
use our convenient form, e-mail subscriptions@townsendletter.com, or call 360.385.6021.

360.385.6021
Fax: 360.385.0699
info@townsendletter.com